Our expertise
Supported by our scientific and technical expertise, we provide services to meet clinical needs for personalized medicine. At the crossroads between industry and research, our team shows a unique savoir-faire.
Our solutions are based on a clever mix of:
Molecular biology
Cellular biology
Radiobiology
Biological samples
Translational research
Industrial development

Our
R&D cell
Innovation is at the heart of our DNA
The mission of our R&D unit is to innovate, develop and create new tests in order to propose new solutions adapted to each patient. We collaborate with research laboratories, in particular the INSERM UMR 1296 academic laboratory “Radiation: defense, health, environment”, directed by Dr Nicolas Foray, in Lyon, to carry out our developments.
Our R&D unit focuses on:
- Improving processes in order to develop simpler, faster and more efficient systems while maintaining diagnostic precision
- The creation of new solutions
- applied to new diseases / technological and scientific monitoring
Our patented technology
Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity.
CANCERS (BASEL). 2021 MAY 19;13(10):2477. DOI: 10.3390/CANCERS13102477. PMID: 34069662; PMCID: PMC8160794. Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S
Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity.
CANCERS (BASEL). 2021 MAY 19;13(10):2477. DOI: 10.3390/CANCERS13102477. PMID: 34069662; PMCID: PMC8160794. Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S